Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control

By Kwissa M.   von Kampen v.K.J.   Zurbriggen R.   Gluck R.   Reimann J.   Schirmbeck R.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2337-2344

Elsevier

Access to resources Recommend Favorite

Effective antibody response in newborn babies living in Maldives to simultaneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus

By Da Villa G.   Picciotto L.   Ribera G.   Bencivenga M.   Cotugno M.   Hartmann P.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 795-798

Elsevier

Access to resources Recommend Favorite

Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection

By Johnson D.   Waddell R.D.   Pelton S.I.   Jaeger A.S.   Modlin J.F.   Yogev R.   Morin P.   Arbeit R.D.   Fordham von Reyn C.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2583-2587

Elsevier

Access to resources Recommend Favorite

Cost-effectiveness of hepatitis B vaccination of prison inmates

By Pisu M.   Meltzer M.I.   Lyerla R.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 312-321

Elsevier

Access to resources Recommend Favorite

Hepatitis B vaccination: how to reach risk groups

By Francois G.   Hallauer J.   Van Damme P.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 1-4

Elsevier

Access to resources Recommend Favorite